InvestorsHub Logo
Followers 1
Posts 44
Boards Moderated 0
Alias Born 03/06/2020

Re: None

Wednesday, 04/15/2020 6:42:54 AM

Wednesday, April 15, 2020 6:42:54 AM

Post# of 40501
Shorts have 3 arguments why the price should fall: ”40 years”, ”Kimmie is bad” and ”this is a scam,” I have not 3 but 42 (!!!) reasons to buy shares in Inovio.

42 potential triggers that would make the price go up, let´s see which one will be the first:

1. Clinical trials starting in South Korea and China
2. More funding from The Gates Fundation
3. Updates from already started human trials in the US (Covid-19)
4. Positive results from the ”extra” animal tests in Australia (Covid-19)
5. An increase of doses, from one million to 5-10 million, by the end of the year (Covid-19)
6. More upgraded analyses
7. The company mentioned by name by the president, not only ”a company that has started clinical trials” to give us even more publicity
8. Positive results from other vaccine candidats in clinical trials
9. A ”push” forward from the government to help the company speeding up the process even more
10. A buy out offer from Big pharma
11. Dilution finished
12. More countries contributing with more money to our partner Cepi
13. Positive results from some of the phase 2 vaccines
14. Phase 3 trial start of VGX-3100 against HPV-associated Vulvar Dysplasia
15. Positive results from the other ”extra” animal test supported by WHO
16. Cepi to claim that Inovio is their ”flagship” in the race towards a vaccine, which they already have shown by giving the largest funding to us
17. Shorts forced to cover big time
18. Lawsuit spammers gone
19. New cooperation regarding the manufacture
20. Dep. of Defense with increased cooperation
21. More funding from Cepi
22. Here you can see GE describing Inovio as one of the vaccine leaders. https://www.ge.com/reports/5-ways-the-world-fought-back-4/
With GE selling another Bio-company they now have plenty of cash… Hmm..
23. Start date for manufacturing (Dep. Of Defense)
24. Published comparison of point-of-care cost of potential vaccines
(a DNA Vaccine will ultimately cost the lowest dollars per patient; RNA Vaccines or artificial Ab's will cost multiples more because of cold chain requirements)
25. Published primate preclinical data.
26. Popular press about the importance/difference of therapeutic vaccine vs prophylactic vaccine. I wonder if Inovio is doing primate trials both as therapy and prophylaxis.
(I am not sure but think only Inovio and artificial Ab's can be described as therapeutic. Inovio's vaccine directly stimulates T-cell responses, especially important in Covid-19 response, as T-cells in lung succumb to SARS-Covid-2. Note that the only cancer vaccine on the market, Provenge, works in a way similar to Inovio's DNA vaccines, through APCs to stimulate T-cell immune responses.)
27. You can store Inovio´s INO-4800 in room temperature. More focus on that.
28. Moderna´s Mrna vaccine needs to be stored at -80 degrees celsius. Compare this with Inovio´s technology.
29. An extended partnership with Beijing Advaccine.
30. A huge partnership with a major player in te UK, thanks to our lovely Kate and her contacts over there (She is from Scotland originally).
31. Delivery of Vaccines to DoD
32. Start of Human trial using INO's Vaccine led by DoD
33. Emergency Use approval for INO's Vaccine
34. Phase 3 trials starting against head and neck cancer, gliobastoma, prostate cancer
35. Extended partnership into Phase 3 trials with Astra Zeneca (Medio 547).
36. Fauci to also support Inovio.
37. Chinese hedgefunds to increase their positions.
38. Foresight of the pandemy ”surviving” until a vaccine/vaccines is around.
39. Evidence of humans not being 100 % immune after having Covid-19
40. Help from FDA to speed up the process.
41. Inovio being better to communicate with the public.
42. Giving the symphatic Dr Kate even more space.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INO News